Development of a new immunochemistry method using antibodies of proteins related pancreatic cancer in the pancreatic cancer cell
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0004515
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET-CT)
2. Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
3. Patients who underwent surgical treatment with pancreatic cancer
Exclusion Criteria
1. Minors under the age of 19, vulnerable subjects such as illiteracy
2. Excludes necrotic specimens
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of differentiation power between conventional staining method and new staining by degree of expression in new immunochemistry staining using antibodies of aminoacyl-tRNA synthetases group and aminoacyl-tRNA synthetases-interacting multifunctional protein2 lacking exon 2 in the pancreatic cancer cell and normal pancreatic tissue
- Secondary Outcome Measures
Name Time Method Efficacy of staining method(the sensitivity, specificity, accuracy, positive predictive value and negative predictive value)